reports
- Guy Sips
Amoéba Brazil: an attractive growth market for biocontrol – AXPERA sho...
Amoéba has conducted, in partnership with Koppert, an extensive programme of field trials in Brazil to assess the potential of its AXPERA biofungicide technology on several key crops, such as soya and orange trees, of which Brazil is the world's leading producer. We maintain our Buy and € 1.4 Target Price.
Voltalia SA: Total number of shares and voting rights in the share cap...
Voltalia SA: Total number of shares and voting rights in the share capital as of March 31, 2026 Total number of shares and voting rights in the share capital as of March 31, 2026 (Articles L. 233-8 (II) of the French Commercial Code and 223-16 of the General Regulations of the French Financial Markets Authority) Date Total number of shares in the capital Number of theoretical voting rights Number of exercisable voting rights 03/31/2026 131 318 716223 406 008223 008 319 Next on the agenda: Q1 2026 turnover, April 23, 2026 (after market close) About Voltalia () Voltalia is an intern...
Voltalia SA : Nombre total de droits de vote et d’actions composant le...
Voltalia SA : Nombre total de droits de vote et d’actions composant le capital en date du 31 mars 2026 Nombre total de droits de vote et d’actions composant le capital en date du 31 mars 2026 (Art. L. 233-8 (II) du Code de Commerce et Art. 223-16 du Règlement Général de l’AMF) Date Nombre d’actions composant le capitalNombre de droits de vote théoriquesNombre de droits de vote exerçables31/03/2026 131 318 716223 406 008223 008 319 Prochain rendez-vous : Chiffre d’affaires du premier trimestre 2026, le 23 avril 2026 (après bourse) A propos de Voltalia ()Voltalia...
- Tobias Fahrenholz
- Tobias Fahrenholz
- Martial Descoutures
Abivax : Pourquoi la maladie de Crohn est-elle un enjeu majeur pour Ab...
À ce stade, l’intérêt spéculatif autour d’Abivax semble encore largement être orienté par obefazimod dans la rectocolite ulcéreuse (RCH). Cependant, la maladie de Crohn pourrait constituer un levier de croissance supplémentaire majeur, susceptible d’élargir significativement le marché adressable et d’augmenter l’attractivité stratégique du programme. Dans cette perspective, le read-out de l’étude ENHANCE-CD, attendu au S2 26, représente l’un des catalyseurs les plus importants sur le titre. Nous...
- Martial Descoutures
Abivax : Why does Crohn's disease represent a major opportunity for Ab...
At this stage, speculative interest in Abivax still appears to be largely focused on obefazimod in ulcerative colitis (UC). However, Crohn's disease could represent a major additional growth driver, likely to significantly expand the addressable market and increase the strategic appeal of the programme. With this in mind, the read-out of the ENHANCE-CD study, expected in H2 2026, will be one of the most important catalysts on the project. We maintain our Outperform recommendation.
Mise en service de la centrale solaire de Bolobedu en Afrique du Sud
Mise en service de la centrale solaire de Bolobedu en Afrique du Sud Mise en service de la centrale solaire de Bolobedu en Afrique du Sud Voltalia (Euronext Paris, code ISIN : FR0011995588), acteur international des énergies renouvelables, annonce la mise en service complète1 de la centrale solaire de Bolobedu, située dans la province du Limpopo, en Afrique du Sud. Ce projet, d’une capacité installée totale de 148 mégawatts, est l’un des plus importants en Afrique du Sud dédiés à l’approvisionnement énergétique d’une seule entreprise, via le réseau de transport d’Eskom dans le cadre d’un ...
Bolobedu Solar power plant reaches commissioning in South Africa
Bolobedu Solar power plant reaches commissioning in South Africa Bolobedu Solar power plant reaches commissioning in South Africa Voltalia (Euronext Paris, ISIN code: FR0011995588), an international player in renewable energies announces the full commissioning1 of Bolobedu solar farm, located in South Africa’s Limpopo province. This project, with a total installed capacity of 148 megawatts, is one of the largest in South Africa dedicated to meet the energy needs of a single company via Eskom Transmission Network through a wheeling agreement. It is part of a long-term contract (CPPA) with...
Voltalia SA: Total number of shares and voting rights in the share cap...
Voltalia SA: Total number of shares and voting rights in the share capital as of February 28, 2026 Total number of shares and voting rights in the share capital as of February 28, 2026 (Articles L. 233-8 (II) of the French Commercial Code and 223-16 of the General Regulations of the French Financial Markets Authority) Date Total number of shares in the capital Number of theoretical voting rights Number of exercisable voting rights 02/28/2026 131 318 716223 407 029222 999 753 Next on the agenda: Q1 2026 turnover, April 23, 2026 (after market close) About Voltalia () Voltalia is an...
Voltalia SA : Nombre total de droits de vote et d’actions composant le...
Voltalia SA : Nombre total de droits de vote et d’actions composant le capital en date du 28 février 2026 Nombre total de droits de vote et d’actions composant le capital en date du 28 février 2026 (Art. L. 233-8 (II) du Code de Commerce et Art. 223-16 du Règlement Général de l’AMF) Date Nombre d’actions composant le capitalNombre de droits de vote théoriquesNombre de droits de vote exerçables28/02/2026 131 318 716223 407 029222 999 753 Prochain rendez-vous : Chiffre d’affaires du premier trimestre 2026, le 23 avril 2026 (après bourse) A propos de Voltalia ()Vo...
Information Regarding the Total Number of Voting Rights and Total Numb...
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of March 31, 2026 Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of March 31, 2026 (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers) Market : NYSE Euronext Paris ISIN Code: FR 0010417345 Date Total number of sharesTotal number of voting rights03/31/2026 296,042,447 Total gross of voting rights: 296,042,447 Total net* of voting rights: 295,914,379 * Net total = total number of voting rights attached t...
Information relative au nombre total des droits de vote et d’actions c...
Information relative au nombre total des droits de vote et d’actions composant le capital social au 31 mars 2026 Information relative au nombre total des droits de vote et d’actions composant le capital social au 31 mars 2026 (Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers) Place de cotation : NYSE Euronext Paris Code ISIN : FR 0010417345 Date Nombre totald’actionscomposant le capital socialNombre totalde droits de vote31/03/2026 296.042.447 Total brut des droits de vote :296.042.447 Total net* des droits de vote :295.914.379 *Total net = nombre total de dro...
- Christophe-Raphaël Ganet
- Ahmed Ben Salem
- Thomas Zlowodzki
EQNR EQUINOR ASA
PROX PROXIMUS SA DE DROIT PUBLIC
GALP GALP ENERGIA SGPS SA CLASS B
BVI BUREAU VERITAS SA
SDG SYNERGIE SA
ITRK INTERTEK GROUP PLC
VETO VETOQUINOL SA
ENI ENI S.P.A.
MBB MBB INDUSTRIES SE
NANO NANOBIOTIX SA
REP REPSOL SA
ARG ARGAN SA
IDR INDRA SISTEMAS S.A. CLASS A
BP. BP P.L.C.
DMP DERMAPHARM HOLDING SE
ERF EUROFINS SCIENTIFIC SOCIETE EUROPEENNE
ANR ANSWEAR.COM
AERO MONTANA AEROSPACE AG
SHEL SHELL PLC
SGSN SGS SA
Abivax Publishes Financial Reports with the French and U.S. Securities...
Abivax Publishes Financial Reports with the French and U.S. Securities Regulatory Agencies Abivax Publishes Financial Reports with the French and U.S. Securities Regulatory Agencies Abivax publishes financial reports with the French and U.S. securities regulatory agencies PARIS, France – April 1, 2026 – 10:05 PM CEST – Abivax SA (Euronext Paris: FR0012333284 – ABVX / Nasdaq: ABVX) (“Abivax” or the “Company”), a clinical-stage biotechnology company focused on developing therapeutics that harness the body’s natural regulatory mechanisms to stabilize the immune response in patients with chr...
- Emmanuel Matot
- Roy Külter
- Steven Boumans
NK IMERYS SA
LI KLEPIERRE SA
COV COVIVIO SA
GFC GECINA SA
NXI NEXITY SA CLASS A
GYC GRAND CITY PROPERTIES SA
LEI LEIFHEIT AG
MERY MERCIALYS SA
INEA FONCIERE INEA
WHA WERELDHAVE N.V.
BLND BRITISH LAND COMPANY PLC
VETO VETOQUINOL SA
KOF KAUFMAN & BROAD SA
ALTA ALTAREA SCA
VNA VONOVIA SE
MOBN MOBIMO HOLDING AG
XIOR XIOR STUDENT HOUSING N.V.
ICAD ICADE SA
BYG BIG YELLOW GROUP PLC
UTG UNITE GROUP PLC
IDIP INSTITUT DE DEVELOPPEMENT INDUSTRIEL SCA
COFB COFINIMMO SA
CAI CA IMMOBILIEN ANLAGEN AG
TEG TAG IMMOBILIEN AG
VASTB VASTNED RETAIL BELGIUM NV
ALLN ALLREAL HOLDING AG
KOMN KOMAX HOLDING AG
PSPN PSP SWISS PROPERTY AG
UBS UBM DEVELOPMENT AG
SPSN SWISS PRIME SITE AG
PAT PATRIZIA AG
MONT MONTEA SCA
AED AEDIFICA SA
CARM CARMILA SAS
LEG LEG IMMOBILIEN AG
IRES IRISH RESIDENTIAL PROPERTIES REIT PLC
CPINV CARE PROPERTY INVEST SA
SAFE SAFESTORE HOLDINGS PLC
ARG ARGAN SA
VGP VGP NV
COL INMOBILIARIA COLONIAL SOCIMI SA
DIC DIC ASSET AG
MERLIN MERLIN PROPERTIES SOCIMI S.A.
IREN INVESTIS HOLDING SA
SRE SIRIUS REAL ESTATE LIMITED
HOME NEINOR HOMES SA
AT1 AROUNDTOWN SA
LAND LAND SECURITIES GROUP PLC
MVC METROVACESA SA
IGD IMMOBILIARE GRANDE DISTRIBUZIONE SIIQ S.P.A.
NSI NSI N.V.
ULA UNIBAIL-RODAMCO-WESTFIELD SE STAPLED SECS CONS OF 1 SH UNIBAIL RODAMCO + 1 SH WFD UNIB ROD
INS INSTONE REAL ESTATE GROUP AG
AEDAS AEDAS HOMES SA
WDP WAREHOUSES DE PAUW SCA
ECMPA EUROCOMMERCIAL PROPERTIES NV
ALAFY AFYREN
CTPNV CTP NV
SHUR SHURGARD SELF STORAGE LIMITED
4X0 STEYR MOTORS AG
IS INTERSHOP HOLDING AG
Voltalia strengthens its financial flexibility with the support of it...
Voltalia strengthens its financial flexibility with the support of its main shareholder as part of the acceleration of the SPRING plan Voltalia strengthens its financial flexibility with the support of its main shareholder as part of the acceleration of the SPRING planSigning of a 100 million euros regulated agreement Voltalia (Euronext Paris, code ISIN: FR0011995588), an international player in renewable energies, publishes the signing of a regulated agreement entered into pursuant to Articles L.221013 and R.221019 of the French Commercial Code. On the occasion of the presentation of it...
Voltalia renforce sa flexibilité financière avec l’accompagnement de s...
Voltalia renforce sa flexibilité financière avec l’accompagnement de son actionnaire de référence dans le cadre de l’accélération du plan SPRING Voltalia renforce sa flexibilité financière avec l’accompagnement de son actionnaire de référence dans le cadre de l’accélération du plan SPRINGSignature d’une convention réglementée de 100 millions d’euros Voltalia (Euronext Paris, code ISIN : FR0011995588), acteur international des énergies renouvelables, annonce la signature d’une convention réglementée conclue en application des articles L.22‑10‑13 et R.22‑10‑19 du Code de commerce. À l’occas...
Availability of the Universal Registration Document 2025
Availability of the Universal Registration Document 2025 Availability of the Universal Registration Document 2025 Voltalia (Euronext Paris, ISIN code: FR0011995588), an international player in renewable energy, today announces the publication of its Universal Registration Document 2025 Voltalia announces that it has filed with the Autorité des Marchés Financiers and made available to the public its Universal Registration Document (period from 1 January 2025 to 31 December 2025) under the number D26-0181. The Universal Registration Document includes the following information: the Annual...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.